Jason Hoitt, Chief Commercial Officer at Provention Bio, Inc. (PRVB), sold 4,500 shares at $10.00 ($45K) on 2023-02-10, disclosed to the SEC on 2023-02-14.
Scheduled sale ($45k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DOVA | SELL | 2019-10-02 | $67K | — | Filing → |
| DOVA | SELL | 2019-07-16 | $116K | — | Filing → |
| DOVA | SELL | 2019-07-02 | $33K | — | Filing → |